Although most life sciences businesses had already started down the path toward digitally transforming, the impact of the pandemic has created a greater sense of urgency. Seemingly overnight, pharmaceutical and medical device companies saw a significant surge in demand – all while struggling to address supply chain disruptions and adjust to production capacity issues and workforce constraints.
As they work through these issues, life sciences businesses will likely put a greater focus on digital technology to ensure they are better prepared to handle future disruptions. But the traditional approach to digital transformation, based on large-scale implementation projects, will not work. Today’s environment requires a nimble approach that allows a business to pivot and refocus as business conditions change.
Read the blog